Literature DB >> 24020603

The treatment journey of a patient with multidrug-resistant tuberculosis in South Africa: is it patient-centred?

M Loveday1, N Padayatchi2, A Voce3, J Brust4, K Wallengren5.   

Abstract

To improve the treatment of patients co-infected with multidrug-resistant tuberculosis (MDR-TB) and the human immunodeficiency virus, we measured the relationship between treatment outcomes and hospital performance at four decentralised MDR-TB sites in South Africa. We describe hospital performance from the patient's perspective by the use of a graphic that visually represents a patient's treatment journey. The graphic was used to report study findings to study sites and as a catalyst for a quality improvement process.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24020603      PMCID： PMC3992833          DOI： 10.5588/ijtld.13.0101

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


  11 in total

1.  Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.

Authors:  J C M Brust; N S Shah; M Scott; K Chaiyachati; M Lygizos; T L van der Merwe; S Bamber; Z Radebe; M Loveday; A P Moll; B Margot; U G Lalloo; G H Friedland; N R Gandhi
Journal:  Int J Tuberc Lung Dis       Date:  2012-06-05       Impact factor: 2.373

2.  Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

Authors:  K F Laserson; L E Thorpe; V Leimane; K Weyer; C D Mitnick; V Riekstina; E Zarovska; M L Rich; H S F Fraser; E Alarcón; J P Cegielski; M Grzemska; R Gupta; M Espinal
Journal:  Int J Tuberc Lung Dis       Date:  2005-06       Impact factor: 2.373

3.  Effectiveness of training supervisors to improve reproductive health quality of care: a cluster-randomized trial in Kenya.

Authors:  Heidi W Reynolds; Cathy Toroitich-Ruto; Marlina Nasution; Aaron Beaston-Blaakman; Barbara Janowitz
Journal:  Health Policy Plan       Date:  2007-10-17       Impact factor: 3.344

4.  Prevention of HIV/AIDS among injecting drug users in Russia: opportunities and barriers to scaling-up of harm reduction programmes.

Authors:  Elena Tkatchenko-Schmidt; Adrian Renton; Ruzanna Gevorgyan; Ludmila Davydenko; Rifat Atun
Journal:  Health Policy       Date:  2007-09-04       Impact factor: 2.980

Review 5.  Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.

Authors:  C-Y Chiang; J A Caminero; D A Enarson
Journal:  Int J Tuberc Lung Dis       Date:  2009-05       Impact factor: 2.373

6.  Health systems, systems thinking and innovation.

Authors:  Rifat Atun
Journal:  Health Policy Plan       Date:  2012-10       Impact factor: 3.344

Review 7.  Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches.

Authors:  Mark L Willenbring
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

8.  Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa.

Authors:  M Loveday; K Wallengren; A Voce; B Margot; T Reddy; I Master; J Brust; K Chaiyachati; N Padayatchi
Journal:  Int J Tuberc Lung Dis       Date:  2012-02       Impact factor: 2.373

9.  Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.

Authors:  Ariel Pablos-Mendez; Deepthiman K Gowda; Thomas R Frieden
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

10.  Drug-Resistant tuberculosis, KwaZulu-Natal, South Africa, 2001-2007.

Authors:  Kristina Wallengren; Fabio Scano; Paul Nunn; Bruce Margot; Sandile S S Buthelezi; Brian Williams; Alexander Pym; Elisabeth Y Samuel; Fuad Mirzayev; Wilfred Nkhoma; Lindiwe Mvusi; Yogan Pillay
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883
View more
  13 in total

1.  Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing.

Authors:  Max R O'Donnell; Michelle H Larsen; Tyler S Brown; Paras Jain; Vanisha Munsamy; Allison Wolf; Lorenzo Uccellini; Farina Karim; Tulio de Oliveira; Barun Mathema; William R Jacobs; Alexander Pym
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  A Novel Reporter Phage To Detect Tuberculosis and Rifampin Resistance in a High-HIV-Burden Population.

Authors:  Max R O'Donnell; Alexander Pym; Paras Jain; Vanisha Munsamy; Allison Wolf; Farina Karim; William R Jacobs; Michelle H Larsen
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

3.  Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.

Authors:  Max R OʼDonnell; Melendhran Pillay; Manormoney Pillay; Lise Werner; Iqbal Master; Allison Wolf; Barun Mathema; Yacoob M Coovadia; Koleka Mlisana; Charles Robert Horsburgh; Nesri Padayatchi
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-15       Impact factor: 3.731

4.  Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB).

Authors:  Holly A Taylor; David W Dowdy; Alexandra R Searle; Andrea L Stennett; Vadim Dukhanin; Alice A Zwerling; Maria W Merritt
Journal:  SSM Qual Res Health       Date:  2022-01-28

5.  Diverse clinical and social circumstances: developing patient-centred care for DR-TB patients in South Africa.

Authors:  L Mitrani; L Dickson-Hall; S Le Roux; J Hill; M Loveday; A D Grant; K Kielmann; K Mlisana; M Moshabela; M P Nicol; J Black; H Cox
Journal:  Public Health Action       Date:  2021-09-21

6.  Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.

Authors:  M R O'Donnell; A Daftary; M Frick; Y Hirsch-Moverman; K R Amico; M Senthilingam; A Wolf; J Z Metcalfe; P Isaakidis; J L Davis; J R Zelnick; J C M Brust; N Naidu; M Garretson; D R Bangsberg; N Padayatchi; G Friedland
Journal:  Int J Tuberc Lung Dis       Date:  2016-04       Impact factor: 2.373

7.  Drug-resistant tuberculosis control in South Africa: scientific advances and health system strengthening are complementary.

Authors:  Nesri Padayatchi; Marian Loveday; Naressa Naidu
Journal:  Expert Opin Pharmacother       Date:  2014-10       Impact factor: 3.889

8.  Identifying contextual determinants of problems in tuberculosis care provision in South Africa: a theory-generating case study.

Authors:  Jamie Murdoch; Robyn Curran; André J van Rensburg; Ajibola Awotiwon; Audry Dube; Max Bachmann; Inge Petersen; Lara Fairall
Journal:  Infect Dis Poverty       Date:  2021-05-10       Impact factor: 4.520

9.  Rolling Out Xpert® MTB/RIF for TB Detection in HIV-Infected Populations:An Opportunity for Systems Strengthening.

Authors:  Ishani Pathmanathan; Anand Date; William L Coggin; John Nkengasong; Amy S Piatek; Heather Alexander
Journal:  Afr J Lab Med       Date:  2017-03-31

10.  The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.

Authors:  Pren Naidoo; Grant Theron; Molebogeng X Rangaka; Violet N Chihota; Louise Vaughan; Zameer O Brey; Yogan Pillay
Journal:  J Infect Dis       Date:  2017-11-06       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.